Gilead Sciences (GILD)
$60.79 0.12 (0.20%)
19:59 EDT GILD Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 79.04B
PE Ratio 23.11
Volume (Avg. Vol.) 30.97M
Day's Range 60.76 - 63.64
52-Week Range 59.65 - 85.97
Dividend & Yield 2.23 (3.67%)
GILD Stock Predictions, Articles, and Gilead Sciences News
- From InvestorPlace
- From the Web
Twilio, Gilead Sciences, Snap and Spartan Energy Acquisition are our top stock trades to watch on Monday. And here's why.
Want to know what the big remdesivir approval actually means for Gilead stock? Here's everything investors need to understand.
Gilead stock is climbing higher Thursday after its remdesivir coronavirus treatment received full approval from the FDA. Why it matters.
With rising coronavirus hospitalizations dominating headlines, investors will shift back toward a pandemic mentality. Here are nine stocks to buy to capitalize on this trend.
By Joel Baglole
Investors are banking on an upsurge in pharmaceutical stocks once various vaccines and other therapies gain commercial approval from the U.S. Food and Drug Administration (FDA). Here is a list of pharmaceutical companies that stand to benefit in the coming months.
One way to find undervalued stocks is to use free cash flow yield as a barometer. Here are 10 stocks to buy based on this criterion.
As the race to develop a vaccine continues, these biotech stocks could be high risk, high return propositions.
Pinterest, Crocs, Gilead Sciences, Constellation Brands and ConAgra Foods were our top stock trades from Thursday.
Immunomedics (IMMU) is seeing IMMU stock soar higher Monday following news that it will be acquired by Gilead (GILD) for $21 billion.
A handful of pharmaceutical stocks have been on fire lately, but I'm writing for a "buy" prescription for five of the best names now.
Coronavirus vaccines get all the attention, but these four pharmaceutical stocks benefit from equipment, drug and test kit developments.
Gilead stock has been under pressure for a few months, giving investors a great risk/reward setup, especially with its coronavirus treatment.
Strong sales of Gilead's successful novel coronavirus drug, remdesivir, will ultimately lift GILD stock and reward shareholders.
With a 20-year timeline, you have multiple choices for dividend stocks to buy. Here are 30 names that should do very well.
As the pandemic continues to grow, these four coronavirus stocks are great ways to protect your portfolio for the foreseeable future.
By Ken Trester
Earnings season is upon us, and Johnson & Johnson (NYSE:JNJ) will kick off second-quarter reporting for the big pharmaceutical stocks on July 16.
As pharmaceutical companies rush to manufacture coronavirus vaccine and drugs, it makes sense to hold some potential winners.
From Talk Markets
Navellier RatingsPowered by Portfolio Grader